Recipharm

http://www.recipharm.com

Phone:011/46 8 602 52 00

More from Recipharm

Recipharm Acquires Vibalogics, Arranta Bio

The acquisitions expand Recipharm’s advanced therapy medicinal products (ATMPs) offerings into virotherapies and its biologics offerings in the U.S.

Recipharm Secures Vaccine Manufacturing Deal

In accordance with the agreement, the company will aseptically pack single-use vaccines used to treat a severe infectious disease that affects both young children and infants.

Recipharm Connects to European Hub for Serialization Compliance

Recipharm’s three-year serialization program began in January 2016 and involves a 40-million-euro investment.

Recipharm’s three-year serialization program began in January 2016 and involves a 40-million-euro investment.

Recipharm Connects to European Hub for Serialization Compliance

Recipharm’s three-year serialization program began in January 2016 and involves a 40-million-euro investment.

With Nov. 27, 2017's DSCSA deadline, CDMO Recipharm now has nine locations able to supply serialized products to the U.S. Shown here is product labeling on a Recipharm packaging line.

Recipharm Equips Three More Facilities for U.S. Serialization

With today’s DSCSA deadline, CDMO Recipharm now has nine locations able to supply serialized products to the U.S.

Recipharm makes strategic appointment in the UK & Ireland

Recipharm, the contract development and manufacturing organisation (CDMO), has invested in its UK & Ireland presence with the appointment of Shabbir Mostafa to its Business Management team.

Recipharm opens new GMP suite for clinical trial material

Recipharm Delivers First Serialized Batch to Saudi Arabia

The €300,000 project, which is in addition to a wider €40 million investment into new serialization technology and processes to comply with the European Falsified Medicines Directive (FMD), enables Recipharm to supply serialized products to Saudi Arabia.

Shown here is a Recipharm carton as it's labeled.

Recipharm Delivers First Serialized Batch to Saudi Arabia

The €300,000 project, which is in addition to a wider €40 million investment into new serialization technology and processes to comply with the European Falsified Medicines Directive (FMD), enables Recipharm to supply serialized products to Saudi Arabia.